Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15Stomatitis 14Head and Neck Neoplasms 14Neoplasms 7Radiodermatitis 6Lymphedema 6Mucositis 5Xerostomia 4Trismus 3Ulcer 2Squamous Cell Carcinoma of Head and Neck 2Radiation Injuries 2Peripheral Nervous System Diseases 2Hematologic Neoplasms 2Fibrosis 2Dermatitis 2Breast Cancer Lymphedema 2Wounds and Injuries 1Taste Disorders 1Skin Diseases 1Radiation Induced Xerostomia 1Radiation Fibrosis Syndrome 1Pain 1Ovarian Neoplasms 1Oral Ulcer 1Neuralgia 1Mouth Neoplasms 1Hand-Foot Syndrome 1Graft vs Host Disease 1Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 64Tacrolimus 55Methotrexate 46Mycophenolic Acid 39Cyclosporine 37fludarabine phosphate 35Busulfan 35Antilymphocyte Serum 32fludarabine 29Sirolimus 26Melphalan 23Peripheral Blood Stem Cell Transplantation 22Radiotherapy 21Methylprednisolone 21Whole-Body Irradiation 19Filgrastim 17thymoglobulin 14Thiotepa 11Stem Cell Transplantation 10Rituximab 10ruxolitinib 9Granulocyte Colony-Stimulating Factor 9Prednisone 7Hematopoietic Stem Cell Transplantation 7Etoposide 7Cord Blood Stem Cell Transplantation 7Alemtuzumab 7Pentostatin 6Cytarabine 6Transplantation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Graft vs Host Disease × Low-Level Light Therapy × Clear all
NCT05675930 2026-05-22

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
44 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡